A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MOREIRA, Fernanda de Lima et al. Optimizing therapeutic drug monitoring in pregnant women: a critical literature review. Therapeutic Drug Monitoring, v. 45, n. 2, p. 159-172, 2023Tradução . . Disponível em: https://doi.org/10.1097/FTD.0000000000001039. Acesso em: 19 ago. 2024.
APA
Moreira, F. de L., Benzi, J. R. de L., Pinto, L., Thomaz, M. de L., Duarte, G., & Lanchote, V. L. (2023). Optimizing therapeutic drug monitoring in pregnant women: a critical literature review. Therapeutic Drug Monitoring, 45( 2), 159-172. doi:10.1097/FTD.0000000000001039
NLM
Moreira F de L, Benzi JR de L, Pinto L, Thomaz M de L, Duarte G, Lanchote VL. Optimizing therapeutic drug monitoring in pregnant women: a critical literature review [Internet]. Therapeutic Drug Monitoring. 2023 ; 45( 2): 159-172.[citado 2024 ago. 19 ] Available from: https://doi.org/10.1097/FTD.0000000000001039
Vancouver
Moreira F de L, Benzi JR de L, Pinto L, Thomaz M de L, Duarte G, Lanchote VL. Optimizing therapeutic drug monitoring in pregnant women: a critical literature review [Internet]. Therapeutic Drug Monitoring. 2023 ; 45( 2): 159-172.[citado 2024 ago. 19 ] Available from: https://doi.org/10.1097/FTD.0000000000001039
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MOREIRA, Fernanda de Lima et al. P-Glycoprotein and organic anion transporter polypeptide 1B/breast cancer resistance protein drug transporter activity in pregnant women living with HIV. The Journal of Clinical Pharmacology, v. 63, n. 2, p. 219-227, 2023Tradução . . Disponível em: https://doi.org/10.1002/jcph.2152. Acesso em: 19 ago. 2024.
APA
Moreira, F. de L., Melli, P. P. dos S., Marques, M. P., Rocha, A., Nardotto, G. H. B., Duarte, G., & Lanchote, V. L. (2023). P-Glycoprotein and organic anion transporter polypeptide 1B/breast cancer resistance protein drug transporter activity in pregnant women living with HIV. The Journal of Clinical Pharmacology, 63( 2), 219-227. doi:10.1002/jcph.2152
NLM
Moreira F de L, Melli PP dos S, Marques MP, Rocha A, Nardotto GHB, Duarte G, Lanchote VL. P-Glycoprotein and organic anion transporter polypeptide 1B/breast cancer resistance protein drug transporter activity in pregnant women living with HIV [Internet]. The Journal of Clinical Pharmacology. 2023 ; 63( 2): 219-227.[citado 2024 ago. 19 ] Available from: https://doi.org/10.1002/jcph.2152
Vancouver
Moreira F de L, Melli PP dos S, Marques MP, Rocha A, Nardotto GHB, Duarte G, Lanchote VL. P-Glycoprotein and organic anion transporter polypeptide 1B/breast cancer resistance protein drug transporter activity in pregnant women living with HIV [Internet]. The Journal of Clinical Pharmacology. 2023 ; 63( 2): 219-227.[citado 2024 ago. 19 ] Available from: https://doi.org/10.1002/jcph.2152
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RODRIGUES, Grazielle de Fátima Pinto et al. Enhanced elimination of betamethasone in dichorionic twin pregnancies. British Journal of Clinical Pharmacology, v. 88, n. 4, p. 1897-1903, 2022Tradução . . Disponível em: https://doi.org/10.1111/bcp.15111. Acesso em: 19 ago. 2024.
APA
Rodrigues, G. de F. P., Benzi, J. R. de L., Matos, L. H. de C., Freitas, S. F. de, Marques, M. P., Cavalli, R. de C., et al. (2022). Enhanced elimination of betamethasone in dichorionic twin pregnancies. British Journal of Clinical Pharmacology, 88( 4), 1897-1903. doi:10.1111/bcp.15111
NLM
Rodrigues G de FP, Benzi JR de L, Matos LH de C, Freitas SF de, Marques MP, Cavalli R de C, Moisés ECD, Duarte G, Lanchote VL, Marcolin AC. Enhanced elimination of betamethasone in dichorionic twin pregnancies [Internet]. British Journal of Clinical Pharmacology. 2022 ; 88( 4): 1897-1903.[citado 2024 ago. 19 ] Available from: https://doi.org/10.1111/bcp.15111
Vancouver
Rodrigues G de FP, Benzi JR de L, Matos LH de C, Freitas SF de, Marques MP, Cavalli R de C, Moisés ECD, Duarte G, Lanchote VL, Marcolin AC. Enhanced elimination of betamethasone in dichorionic twin pregnancies [Internet]. British Journal of Clinical Pharmacology. 2022 ; 88( 4): 1897-1903.[citado 2024 ago. 19 ] Available from: https://doi.org/10.1111/bcp.15111
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GONÇALVES, Paulo Vinícius Bernardes et al. Nonrelevant pharmacokinetic drug-drug interaction between furosemide and pindolol enantiomers in hypertensive parturient women [Carta]. The Journal of Clinical Pharmacology. Hoboken: Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1002/jcph.1719. Acesso em: 19 ago. 2024. , 2020
APA
Gonçalves, P. V. B., Moreira, F. de L., Benzi, J. R. de L., Cavalli, R. de C., Duarte, G., & Lanchote, V. L. (2020). Nonrelevant pharmacokinetic drug-drug interaction between furosemide and pindolol enantiomers in hypertensive parturient women [Carta]. The Journal of Clinical Pharmacology. Hoboken: Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo. doi:10.1002/jcph.1719
NLM
Gonçalves PVB, Moreira F de L, Benzi JR de L, Cavalli R de C, Duarte G, Lanchote VL. Nonrelevant pharmacokinetic drug-drug interaction between furosemide and pindolol enantiomers in hypertensive parturient women [Carta] [Internet]. The Journal of Clinical Pharmacology. 2020 ; 60( 11): 1527-1529.[citado 2024 ago. 19 ] Available from: https://doi.org/10.1002/jcph.1719
Vancouver
Gonçalves PVB, Moreira F de L, Benzi JR de L, Cavalli R de C, Duarte G, Lanchote VL. Nonrelevant pharmacokinetic drug-drug interaction between furosemide and pindolol enantiomers in hypertensive parturient women [Carta] [Internet]. The Journal of Clinical Pharmacology. 2020 ; 60( 11): 1527-1529.[citado 2024 ago. 19 ] Available from: https://doi.org/10.1002/jcph.1719
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BENZI, Jhohann Richard de Lima et al. A background subtraction approach for determination of endogenous cortisol and 6β-hydroxycortisol in urine by UPLC-MS/MS with application in a within-day variability study in HIV-infected pregnant women. Journal of Chromatography B, v. 1144 , 2020Tradução . . Disponível em: https://doi.org/10.1016/j.jchromb.2020.122074. Acesso em: 19 ago. 2024.
APA
Benzi, J. R. de L., Moreira, F. de L., Marques, M. P., Duarte, G., Suarez-Kurtz, G., & Lanchote, V. L. (2020). A background subtraction approach for determination of endogenous cortisol and 6β-hydroxycortisol in urine by UPLC-MS/MS with application in a within-day variability study in HIV-infected pregnant women. Journal of Chromatography B, 1144 . doi:10.1016/j.jchromb.2020.122074
NLM
Benzi JR de L, Moreira F de L, Marques MP, Duarte G, Suarez-Kurtz G, Lanchote VL. A background subtraction approach for determination of endogenous cortisol and 6β-hydroxycortisol in urine by UPLC-MS/MS with application in a within-day variability study in HIV-infected pregnant women [Internet]. Journal of Chromatography B. 2020 ; 1144 [citado 2024 ago. 19 ] Available from: https://doi.org/10.1016/j.jchromb.2020.122074
Vancouver
Benzi JR de L, Moreira F de L, Marques MP, Duarte G, Suarez-Kurtz G, Lanchote VL. A background subtraction approach for determination of endogenous cortisol and 6β-hydroxycortisol in urine by UPLC-MS/MS with application in a within-day variability study in HIV-infected pregnant women [Internet]. Journal of Chromatography B. 2020 ; 1144 [citado 2024 ago. 19 ] Available from: https://doi.org/10.1016/j.jchromb.2020.122074
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GONÇALVES, Paulo Vinícius Bernardes et al. A pilot study of the maternal-fetal pharmacokinetics of furosemide in plasma, urine, and amniotic fluid of hypertensive parturient women under cesarean section. The Journal of Clinical Pharmacology, v. 60, n. 12, p. 1655-1661, 2020Tradução . . Disponível em: https://doi.org/10.1002/jcph.1681. Acesso em: 19 ago. 2024.
APA
Gonçalves, P. V. B., Moreira, F. de L., Benzi, J. R. de L., Duarte, G., & Lanchote, V. L. (2020). A pilot study of the maternal-fetal pharmacokinetics of furosemide in plasma, urine, and amniotic fluid of hypertensive parturient women under cesarean section. The Journal of Clinical Pharmacology, 60( 12), 1655-1661. doi:10.1002/jcph.1681
NLM
Gonçalves PVB, Moreira F de L, Benzi JR de L, Duarte G, Lanchote VL. A pilot study of the maternal-fetal pharmacokinetics of furosemide in plasma, urine, and amniotic fluid of hypertensive parturient women under cesarean section [Internet]. The Journal of Clinical Pharmacology. 2020 ; 60( 12): 1655-1661.[citado 2024 ago. 19 ] Available from: https://doi.org/10.1002/jcph.1681
Vancouver
Gonçalves PVB, Moreira F de L, Benzi JR de L, Duarte G, Lanchote VL. A pilot study of the maternal-fetal pharmacokinetics of furosemide in plasma, urine, and amniotic fluid of hypertensive parturient women under cesarean section [Internet]. The Journal of Clinical Pharmacology. 2020 ; 60( 12): 1655-1661.[citado 2024 ago. 19 ] Available from: https://doi.org/10.1002/jcph.1681
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PINTO, Leonardo Santos Ribeiro et al. Chiral discrimination of p-glycoprotein in parturient women: effect of fluoxetine on maternal-fetal fexofenadine pharmacokinetics. Pharmaceutical Research, v. 37, n. 7, 2020Tradução . . Disponível em: https://doi.org/10.1007/s11095-020-02854-4. Acesso em: 19 ago. 2024.
APA
Pinto, L. S. R., Moreira, F. de L., Nardotto, G. H. B., Cavalli, R. de C., Moisés, E. C. D., Duarte, G., & Lanchote, V. L. (2020). Chiral discrimination of p-glycoprotein in parturient women: effect of fluoxetine on maternal-fetal fexofenadine pharmacokinetics. Pharmaceutical Research, 37( 7). doi:10.1007/s11095-020-02854-4
NLM
Pinto LSR, Moreira F de L, Nardotto GHB, Cavalli R de C, Moisés ECD, Duarte G, Lanchote VL. Chiral discrimination of p-glycoprotein in parturient women: effect of fluoxetine on maternal-fetal fexofenadine pharmacokinetics [Internet]. Pharmaceutical Research. 2020 ; 37( 7):[citado 2024 ago. 19 ] Available from: https://doi.org/10.1007/s11095-020-02854-4
Vancouver
Pinto LSR, Moreira F de L, Nardotto GHB, Cavalli R de C, Moisés ECD, Duarte G, Lanchote VL. Chiral discrimination of p-glycoprotein in parturient women: effect of fluoxetine on maternal-fetal fexofenadine pharmacokinetics [Internet]. Pharmaceutical Research. 2020 ; 37( 7):[citado 2024 ago. 19 ] Available from: https://doi.org/10.1007/s11095-020-02854-4
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOUZA, Marília Cristina Oliveira et al. Pharmacokinetics and placental transfer of bupivacaine enantiomers in HIV-infected parturient women on antiretroviral therapy. The Journal of Clinical Pharmacology, v. 60, n. 5, p. 566-572, 2020Tradução . . Disponível em: https://doi.org/10.1002/jcph.1554. Acesso em: 19 ago. 2024.
APA
Souza, M. C. O., Pereira, M. P. M., Duarte, G., & Lanchote, V. L. (2020). Pharmacokinetics and placental transfer of bupivacaine enantiomers in HIV-infected parturient women on antiretroviral therapy. The Journal of Clinical Pharmacology, 60( 5), 566-572. doi:10.1002/jcph.1554
NLM
Souza MCO, Pereira MPM, Duarte G, Lanchote VL. Pharmacokinetics and placental transfer of bupivacaine enantiomers in HIV-infected parturient women on antiretroviral therapy [Internet]. The Journal of Clinical Pharmacology. 2020 ; 60( 5): 566-572.[citado 2024 ago. 19 ] Available from: https://doi.org/10.1002/jcph.1554
Vancouver
Souza MCO, Pereira MPM, Duarte G, Lanchote VL. Pharmacokinetics and placental transfer of bupivacaine enantiomers in HIV-infected parturient women on antiretroviral therapy [Internet]. The Journal of Clinical Pharmacology. 2020 ; 60( 5): 566-572.[citado 2024 ago. 19 ] Available from: https://doi.org/10.1002/jcph.1554
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MOREIRA, Fernanda de Lima et al. Determination of raltegravir and raltegravir glucuronide in human plasma and urine by LC-MS/MS with application in a maternal-fetal pharmacokinetic study. Journal of Pharmaceutical and Biomedical Analysis, v. 177, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.jpba.2019.112838. Acesso em: 19 ago. 2024.
APA
Moreira, F. de L., Marques, M. P., Duarte, G., & Lanchote, V. L. (2020). Determination of raltegravir and raltegravir glucuronide in human plasma and urine by LC-MS/MS with application in a maternal-fetal pharmacokinetic study. Journal of Pharmaceutical and Biomedical Analysis, 177. doi:10.1016/j.jpba.2019.112838
NLM
Moreira F de L, Marques MP, Duarte G, Lanchote VL. Determination of raltegravir and raltegravir glucuronide in human plasma and urine by LC-MS/MS with application in a maternal-fetal pharmacokinetic study [Internet]. Journal of Pharmaceutical and Biomedical Analysis. 2020 ; 177[citado 2024 ago. 19 ] Available from: https://doi.org/10.1016/j.jpba.2019.112838
Vancouver
Moreira F de L, Marques MP, Duarte G, Lanchote VL. Determination of raltegravir and raltegravir glucuronide in human plasma and urine by LC-MS/MS with application in a maternal-fetal pharmacokinetic study [Internet]. Journal of Pharmaceutical and Biomedical Analysis. 2020 ; 177[citado 2024 ago. 19 ] Available from: https://doi.org/10.1016/j.jpba.2019.112838
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CARVALHO, Daniela Miarelli et al. Pharmacokinetics and transplacental transfer of fluoxetine enantiomers and their metabolites in pregnant women. Clinical Pharmacology and Therapeutics, v. 105, n. 4, p. 1003-1008, 2019Tradução . . Disponível em: https://doi.org/10.1002/cpt.1263. Acesso em: 19 ago. 2024.
APA
Carvalho, D. M., Lanchote, V. L., Filgueira, G. C. de O., Nardotto, G. H. B., Duarte, G., Cavalli, R. C., & Moisés, E. C. D. (2019). Pharmacokinetics and transplacental transfer of fluoxetine enantiomers and their metabolites in pregnant women. Clinical Pharmacology and Therapeutics, 105( 4), 1003-1008. doi:10.1002/cpt.1263
NLM
Carvalho DM, Lanchote VL, Filgueira GC de O, Nardotto GHB, Duarte G, Cavalli RC, Moisés ECD. Pharmacokinetics and transplacental transfer of fluoxetine enantiomers and their metabolites in pregnant women [Internet]. Clinical Pharmacology and Therapeutics. 2019 ; 105( 4): 1003-1008.[citado 2024 ago. 19 ] Available from: https://doi.org/10.1002/cpt.1263
Vancouver
Carvalho DM, Lanchote VL, Filgueira GC de O, Nardotto GHB, Duarte G, Cavalli RC, Moisés ECD. Pharmacokinetics and transplacental transfer of fluoxetine enantiomers and their metabolites in pregnant women [Internet]. Clinical Pharmacology and Therapeutics. 2019 ; 105( 4): 1003-1008.[citado 2024 ago. 19 ] Available from: https://doi.org/10.1002/cpt.1263
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOUZA, Marília Cristina Oliveira et al. Analysis of bupivacaine enantiomers in plasma as total and unbound concentrations using LC-MS/MS:: application in a pharmacokinetic study of a parturient with placental transfer. Journal of Pharmaceutical and Biomedical Analysis, v. 164, p. 268-275, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.jpba.2018.10.040. Acesso em: 19 ago. 2024.
APA
Souza, M. C. O., Marques, M. P., Duarte, G., & Lanchote, V. L. (2019). Analysis of bupivacaine enantiomers in plasma as total and unbound concentrations using LC-MS/MS:: application in a pharmacokinetic study of a parturient with placental transfer. Journal of Pharmaceutical and Biomedical Analysis, 164, 268-275. doi:10.1016/j.jpba.2018.10.040
NLM
Souza MCO, Marques MP, Duarte G, Lanchote VL. Analysis of bupivacaine enantiomers in plasma as total and unbound concentrations using LC-MS/MS:: application in a pharmacokinetic study of a parturient with placental transfer [Internet]. Journal of Pharmaceutical and Biomedical Analysis. 2019 ; 164 268-275.[citado 2024 ago. 19 ] Available from: https://doi.org/10.1016/j.jpba.2018.10.040
Vancouver
Souza MCO, Marques MP, Duarte G, Lanchote VL. Analysis of bupivacaine enantiomers in plasma as total and unbound concentrations using LC-MS/MS:: application in a pharmacokinetic study of a parturient with placental transfer [Internet]. Journal of Pharmaceutical and Biomedical Analysis. 2019 ; 164 268-275.[citado 2024 ago. 19 ] Available from: https://doi.org/10.1016/j.jpba.2018.10.040
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RIBEIRO, Rodrigo Metzker Pereira et al. Lopinavir/ritonavir treatment increases the placental transfer of bupivacaine enantiomers in human immunodeficiency virus-infected pregnant women. British Journal of Clinical Pharmacology, v. 84, n. 10, p. 2415-2421, 2018Tradução . . Disponível em: https://doi.org/10.1111/bcp.13700. Acesso em: 19 ago. 2024.
APA
Ribeiro, R. M. P., Moreira, F. de L., Moisés, E. C. D., Cavalli, R. de C., Quintana, S. M., Lanchote, V. L., & Duarte, G. (2018). Lopinavir/ritonavir treatment increases the placental transfer of bupivacaine enantiomers in human immunodeficiency virus-infected pregnant women. British Journal of Clinical Pharmacology, 84( 10), 2415-2421. doi:10.1111/bcp.13700
NLM
Ribeiro RMP, Moreira F de L, Moisés ECD, Cavalli R de C, Quintana SM, Lanchote VL, Duarte G. Lopinavir/ritonavir treatment increases the placental transfer of bupivacaine enantiomers in human immunodeficiency virus-infected pregnant women [Internet]. British Journal of Clinical Pharmacology. 2018 ; 84( 10): 2415-2421.[citado 2024 ago. 19 ] Available from: https://doi.org/10.1111/bcp.13700
Vancouver
Ribeiro RMP, Moreira F de L, Moisés ECD, Cavalli R de C, Quintana SM, Lanchote VL, Duarte G. Lopinavir/ritonavir treatment increases the placental transfer of bupivacaine enantiomers in human immunodeficiency virus-infected pregnant women [Internet]. British Journal of Clinical Pharmacology. 2018 ; 84( 10): 2415-2421.[citado 2024 ago. 19 ] Available from: https://doi.org/10.1111/bcp.13700
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FILGUEIRA, G. et al. Effects of maternal obesity on the delivery outcome during labor induction with misoprostol. 2017, Anais.. London: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, 2017. . Acesso em: 19 ago. 2024.
APA
Filgueira, G., Filgueira, O., Carvalho, D., Marques, M., Rocha, A., Moisés, E. C. D., et al. (2017). Effects of maternal obesity on the delivery outcome during labor induction with misoprostol. In Abstracts. London: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo.
NLM
Filgueira G, Filgueira O, Carvalho D, Marques M, Rocha A, Moisés ECD, Duarte G, Lanchote VL, Cavalli R de C. Effects of maternal obesity on the delivery outcome during labor induction with misoprostol. Abstracts. 2017 ;[citado 2024 ago. 19 ]
Vancouver
Filgueira G, Filgueira O, Carvalho D, Marques M, Rocha A, Moisés ECD, Duarte G, Lanchote VL, Cavalli R de C. Effects of maternal obesity on the delivery outcome during labor induction with misoprostol. Abstracts. 2017 ;[citado 2024 ago. 19 ]
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FILGUEIRA, Gabriela Campos de Oliveira et al. Effects of type 2 diabetes mellitus on the pharmacokinetics and transplacental transfer of nifedipine in hypertensive pregnant women. British Journal of Clinical Pharmacology, v. 83, n. 7, p. 1571-1579, 2017Tradução . . Disponível em: https://doi.org/10.1111/bcp.13226. Acesso em: 19 ago. 2024.
APA
Filgueira, G. C. de O., Filgueira, O. A. S., Carvalho, D. M., Marques, M. P., Moisés, E. C. D., Duarte, G., et al. (2017). Effects of type 2 diabetes mellitus on the pharmacokinetics and transplacental transfer of nifedipine in hypertensive pregnant women. British Journal of Clinical Pharmacology, 83( 7), 1571-1579. doi:10.1111/bcp.13226
NLM
Filgueira GC de O, Filgueira OAS, Carvalho DM, Marques MP, Moisés ECD, Duarte G, Lanchote VL, Cavalli R de C. Effects of type 2 diabetes mellitus on the pharmacokinetics and transplacental transfer of nifedipine in hypertensive pregnant women [Internet]. British Journal of Clinical Pharmacology. 2017 ; 83( 7): 1571-1579.[citado 2024 ago. 19 ] Available from: https://doi.org/10.1111/bcp.13226
Vancouver
Filgueira GC de O, Filgueira OAS, Carvalho DM, Marques MP, Moisés ECD, Duarte G, Lanchote VL, Cavalli R de C. Effects of type 2 diabetes mellitus on the pharmacokinetics and transplacental transfer of nifedipine in hypertensive pregnant women [Internet]. British Journal of Clinical Pharmacology. 2017 ; 83( 7): 1571-1579.[citado 2024 ago. 19 ] Available from: https://doi.org/10.1111/bcp.13226
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CARVALHO, Daniela Miarelli et al. Analysis of fluoxetine and norfluoxetine enantiomers in human plasma and amniotic fluid by LC-MS/MS and its application to clinical pharmacokinetics in pregnant women. Journal of Research Analytica, v. 3, n. 1, p. 1-9, 2017Tradução . . Disponível em: https://www.researchgate.net/publication/316844173_Analysis_of_Fluoxetine_and_Norfluoxetine_Enantiomers_in_Human_Plasma_and_Amniotic_Fluid_by_LC-MSMS_and_Its_Application_to_Clinical_Pharmacokinetics_in_Pregnant_Women. Acesso em: 19 ago. 2024.
APA
Carvalho, D. M., Filgueira, G. C. de O., Marques, M. P., Caris, J. A., Duarte, G., Cavalli, R. de C., et al. (2017). Analysis of fluoxetine and norfluoxetine enantiomers in human plasma and amniotic fluid by LC-MS/MS and its application to clinical pharmacokinetics in pregnant women. Journal of Research Analytica, 3( 1), 1-9. Recuperado de https://www.researchgate.net/publication/316844173_Analysis_of_Fluoxetine_and_Norfluoxetine_Enantiomers_in_Human_Plasma_and_Amniotic_Fluid_by_LC-MSMS_and_Its_Application_to_Clinical_Pharmacokinetics_in_Pregnant_Women
NLM
Carvalho DM, Filgueira GC de O, Marques MP, Caris JA, Duarte G, Cavalli R de C, Lanchote VL, Moisés ECD. Analysis of fluoxetine and norfluoxetine enantiomers in human plasma and amniotic fluid by LC-MS/MS and its application to clinical pharmacokinetics in pregnant women [Internet]. Journal of Research Analytica. 2017 ; 3( 1): 1-9.[citado 2024 ago. 19 ] Available from: https://www.researchgate.net/publication/316844173_Analysis_of_Fluoxetine_and_Norfluoxetine_Enantiomers_in_Human_Plasma_and_Amniotic_Fluid_by_LC-MSMS_and_Its_Application_to_Clinical_Pharmacokinetics_in_Pregnant_Women
Vancouver
Carvalho DM, Filgueira GC de O, Marques MP, Caris JA, Duarte G, Cavalli R de C, Lanchote VL, Moisés ECD. Analysis of fluoxetine and norfluoxetine enantiomers in human plasma and amniotic fluid by LC-MS/MS and its application to clinical pharmacokinetics in pregnant women [Internet]. Journal of Research Analytica. 2017 ; 3( 1): 1-9.[citado 2024 ago. 19 ] Available from: https://www.researchgate.net/publication/316844173_Analysis_of_Fluoxetine_and_Norfluoxetine_Enantiomers_in_Human_Plasma_and_Amniotic_Fluid_by_LC-MSMS_and_Its_Application_to_Clinical_Pharmacokinetics_in_Pregnant_Women
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MOISES, Elaine Christine Dantas et al. Transplacental distribution of lidocaine and its metabolite in peridural anesthesia administered to patients with gestational diabetes mellitus. Reproductive Sciences, v. 22, n. 7, p. 791-797, 2015Tradução . . Disponível em: https://doi.org/10.1177/1933719114561560. Acesso em: 19 ago. 2024.
APA
Moises, E. C. D., Duarte, L. de B., Cavalli, R. de C., Carvalho, D. M., Filgueira, G. C. de O., Marques, M. P., et al. (2015). Transplacental distribution of lidocaine and its metabolite in peridural anesthesia administered to patients with gestational diabetes mellitus. Reproductive Sciences, 22( 7), 791-797. doi:10.1177/1933719114561560
NLM
Moises ECD, Duarte L de B, Cavalli R de C, Carvalho DM, Filgueira GC de O, Marques MP, Lanchote VL, Duarte G. Transplacental distribution of lidocaine and its metabolite in peridural anesthesia administered to patients with gestational diabetes mellitus [Internet]. Reproductive Sciences. 2015 ; 22( 7): 791-797.[citado 2024 ago. 19 ] Available from: https://doi.org/10.1177/1933719114561560
Vancouver
Moises ECD, Duarte L de B, Cavalli R de C, Carvalho DM, Filgueira GC de O, Marques MP, Lanchote VL, Duarte G. Transplacental distribution of lidocaine and its metabolite in peridural anesthesia administered to patients with gestational diabetes mellitus [Internet]. Reproductive Sciences. 2015 ; 22( 7): 791-797.[citado 2024 ago. 19 ] Available from: https://doi.org/10.1177/1933719114561560
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FILGUEIRA, Gabriela Campos de Oliveira et al. Analysis of nifedipine in human plasma and amniotic fluid by liquid chromatography-tandem mass spectrometry and its application to clinical pharmacokinetics in hypertensive pregnant women. Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, v. 993-994, p. 20-25, 2015Tradução . . Disponível em: https://doi.org/10.1016/j.jchromb.2015.04.030. Acesso em: 19 ago. 2024.
APA
Filgueira, G. C. de O., Filgueira, O. A. S., Carvalho, D. M., Marques, M. P., Moisés, E. C. D., Duarte, G., et al. (2015). Analysis of nifedipine in human plasma and amniotic fluid by liquid chromatography-tandem mass spectrometry and its application to clinical pharmacokinetics in hypertensive pregnant women. Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, 993-994, 20-25. doi:10.1016/j.jchromb.2015.04.030
NLM
Filgueira GC de O, Filgueira OAS, Carvalho DM, Marques MP, Moisés ECD, Duarte G, Lanchote VL, Cavalli R de C. Analysis of nifedipine in human plasma and amniotic fluid by liquid chromatography-tandem mass spectrometry and its application to clinical pharmacokinetics in hypertensive pregnant women [Internet]. Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences. 2015 ; 993-994 20-25.[citado 2024 ago. 19 ] Available from: https://doi.org/10.1016/j.jchromb.2015.04.030
Vancouver
Filgueira GC de O, Filgueira OAS, Carvalho DM, Marques MP, Moisés ECD, Duarte G, Lanchote VL, Cavalli R de C. Analysis of nifedipine in human plasma and amniotic fluid by liquid chromatography-tandem mass spectrometry and its application to clinical pharmacokinetics in hypertensive pregnant women [Internet]. Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences. 2015 ; 993-994 20-25.[citado 2024 ago. 19 ] Available from: https://doi.org/10.1016/j.jchromb.2015.04.030
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CAVALLI, Ricardo de Carvalho et al. Influence of type 2 diabetes mellitus on the pharmacokinetics and placental transfer of nifedipine in hypertensive pregnancy women. Pregnancy Hypertension. Amsterdam: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1016/j.preghy.2014.10.249. Acesso em: 19 ago. 2024. , 2015
APA
Cavalli, R. de C., Filgueira, G. C., Lanchote, V. L., Carvalho, D. M., Moisés, E. C. D., & Duarte, G. (2015). Influence of type 2 diabetes mellitus on the pharmacokinetics and placental transfer of nifedipine in hypertensive pregnancy women. Pregnancy Hypertension. Amsterdam: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1016/j.preghy.2014.10.249
NLM
Cavalli R de C, Filgueira GC, Lanchote VL, Carvalho DM, Moisés ECD, Duarte G. Influence of type 2 diabetes mellitus on the pharmacokinetics and placental transfer of nifedipine in hypertensive pregnancy women [Internet]. Pregnancy Hypertension. 2015 ; 5( 1): 122-123.[citado 2024 ago. 19 ] Available from: https://doi.org/10.1016/j.preghy.2014.10.249
Vancouver
Cavalli R de C, Filgueira GC, Lanchote VL, Carvalho DM, Moisés ECD, Duarte G. Influence of type 2 diabetes mellitus on the pharmacokinetics and placental transfer of nifedipine in hypertensive pregnancy women [Internet]. Pregnancy Hypertension. 2015 ; 5( 1): 122-123.[citado 2024 ago. 19 ] Available from: https://doi.org/10.1016/j.preghy.2014.10.249
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CAVALLI, Ricardo de Carvalho et al. Influence of type 2 diabetes mellitus on the pharmacokinetics and placental transfer of nifedipine in hypertensive pregnancy women. 2014, Anais.. New Orleans: ISSHP, 2014. . Acesso em: 19 ago. 2024.
APA
Cavalli, R. de C., Filgueira, G. G., Lanchote, V. L., Filgueira, O. O., Carvalho, D. M., Moisés, E. C., & Duarte, G. (2014). Influence of type 2 diabetes mellitus on the pharmacokinetics and placental transfer of nifedipine in hypertensive pregnancy women. In Final Program and Abstracts. New Orleans: ISSHP.
NLM
Cavalli R de C, Filgueira GG, Lanchote VL, Filgueira OO, Carvalho DM, Moisés EC, Duarte G. Influence of type 2 diabetes mellitus on the pharmacokinetics and placental transfer of nifedipine in hypertensive pregnancy women. Final Program and Abstracts. 2014 ;[citado 2024 ago. 19 ]
Vancouver
Cavalli R de C, Filgueira GG, Lanchote VL, Filgueira OO, Carvalho DM, Moisés EC, Duarte G. Influence of type 2 diabetes mellitus on the pharmacokinetics and placental transfer of nifedipine in hypertensive pregnancy women. Final Program and Abstracts. 2014 ;[citado 2024 ago. 19 ]
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BARALDI, Cláudia de Oliveira et al. Effect of type 2 diabetes mellitus on the pharmacokinetics of metformin in obese pregnant women. Clinical Pharmacokinetics, v. 51, n. 11, p. 743-749, 2012Tradução . . Disponível em: https://doi.org/10.1007/s40262-012-0008-7. Acesso em: 19 ago. 2024.
APA
Baraldi, C. de O., Moisés, E. C. D., Carvalho, T. M. de J. P., Antunes, N. de J., Lanchote, V. L., Duarte, G., & Cavalli, R. de C. (2012). Effect of type 2 diabetes mellitus on the pharmacokinetics of metformin in obese pregnant women. Clinical Pharmacokinetics, 51( 11), 743-749. doi:10.1007/s40262-012-0008-7
NLM
Baraldi C de O, Moisés ECD, Carvalho TM de JP, Antunes N de J, Lanchote VL, Duarte G, Cavalli R de C. Effect of type 2 diabetes mellitus on the pharmacokinetics of metformin in obese pregnant women [Internet]. Clinical Pharmacokinetics. 2012 ; 51( 11): 743-749.[citado 2024 ago. 19 ] Available from: https://doi.org/10.1007/s40262-012-0008-7
Vancouver
Baraldi C de O, Moisés ECD, Carvalho TM de JP, Antunes N de J, Lanchote VL, Duarte G, Cavalli R de C. Effect of type 2 diabetes mellitus on the pharmacokinetics of metformin in obese pregnant women [Internet]. Clinical Pharmacokinetics. 2012 ; 51( 11): 743-749.[citado 2024 ago. 19 ] Available from: https://doi.org/10.1007/s40262-012-0008-7